Biosimilars - A Mid-Year Review 2017

This webinar has ended.


On Wednesday, August 16, we hosted a mid-year review of recent biosimilars litigation, including the Supreme Court’s opinion in Amgen v. Sandoz. Fish attorneys Betsy Flanagan and Michael Amon, discussed the following topics:

  • Recent district court and Federal Circuit litigation
  • Implications of the opinion in Amgen v. Sandoz
  • Recent Patent Trial and Appeal Board cases of note; and the impact of these cases and decisions on the biologics and biosimilars markets.